Related Experiment Video
Updated: Jul 26, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
[Control of autoimmune processes by natural and other non-harmful methods]
J Pekárek1, K Cech, O Nevsímal
1Neurobiologická klinika Fakulty Vseobecného lékarství Karlovy university v Praze.
Bratislavske Lekarske Listy
|June 1, 1997
Summary
A novel immunosuppressive factor (SF) derived from DHL shows promise in treating autoimmune diseases by stimulating CD8+ cells. This factor has demonstrated efficacy in conditions like amyotrophic lateral sclerosis (ALS) and experimental autoimmune encephalomyelitis (EAE).
Area of Science:
- Immunology and Autoimmune Diseases
- Cellular and Molecular Biology
Context:
- Increasing incidence of autoimmune diseases necessitates alternative therapies.
- Current treatments (immunosuppressants, hormonal preparations) have significant side effects, including reduced infection resistance.
- Naturally occurring factors like TGF-beta and interleukins are explored as safer therapeutic options.
Purpose:
- To investigate the therapeutic potential of a novel immunosuppressive factor (SF) isolated from DHL for autoimmune conditions.
- To evaluate the efficacy of SF in stimulating CD8+ suppressor cells in humans.
- To present results of SF application in patients with amyotrophic lateral sclerosis (ALS).
Summary:
- An immunosuppressive substance (SF) isolated from DHL inhibits adjuvant arthritis (AA) in rats.
- In humans, SF stimulates CD8+ T-cells, demonstrating suppressoric activity.
- SF has been successfully applied in various autoimmune diseases, including atopic eczema, multiple sclerosis, polyradiculoneuritis, and ALS. This paper details findings in ALS patients.
- An innovative method using antigen bound to an insoluble carrier (Sforon) effectively inhibits experimental autoimmune encephalomyelitis (EAE) and improves survival rates in affected guinea pigs.
Impact:
- Provides a potential new therapeutic strategy for managing autoimmune diseases with potentially fewer side effects than conventional treatments.
- Highlights the role of CD8+ T-cells in immune suppression and therapeutic interventions.
- Offers a novel antigen-delivery system for inducing tolerance and treating neuroinflammatory conditions like EAE.
More Related Videos
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:20Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...